Those claims are supported by growing adverse event data, mechanistic plausibility, and a developing body of peer-reviewed literature that we think will get us past Daubert
bFGF supports the proliferation of the hair matrix cells responsible for active hair shaft production
Semaglutide emerged from Novo Nordisks systematic GLP-1 analogue optimisation programme as the successor to liraglutide , incorporating structural modifications addressing the three principal pharmacokinetic vulnerabilities of native GLP-1: DPP-IV susceptibility at position 8 addressed by Aib8 alpha-aminoisobutyric acid substitution, proteolytic cleavage at position 34 addressed by Arg34Lys substitution, and the short half-life of unmodified GLP-1 analogues addressed by the C18 fatty diacid conjugation providing tighter albumin binding and longer half-life than liraglutides C16 fatty acid, producing the approximately one-week half-life enabling once-weekly subcutaneous administration
Other GLP-1 tablets, like orforglipron, could become available for weight loss in 2026 after it has been approved by the UKs Medicines and Healthcare products Regulatory Agency (MHRA)
If you're comparing compounds by weight-loss potency, our mazdutide vs tirzepatide vs retatrutide breakdown puts the class in context
Dose changes should be based on treatment response and tolerability
